ERISA Ledger · U.S. DOL EBSA Form 5500 (2024)

Sage Therapeutics, INC.

Official 2024 U.S. DOL Form 5500 summary for Sage Therapeutics, INC. (Sage 401(k) Plan · EIN 27-4486580 · PN 001): $79.94M net assets, 352 active participants, and $12.23 per $10,000 (12.23 bps).

Reported Form 5500 Fee & Service Summary

Plan SponsorSage Therapeutics, INC.
Filing IdentifierSage 401(k) Plan · EIN 27-4486580 · PN 001
Plan Category & State401(k) Defined Contribution (MA)
Asset-Size Peer Cohort$25M-$100M
Plan Net Assets (2024)$79.94M
Active Participants352
Direct Admin Fee Rate$12.23 per $10,000 (12.23 bps)
Cohort Peer Median$19.23 per $10,000 (19.23 bps)
Primary Recordkeeper / ProviderPrincipal Financial Group
Schedule H Line 4a RemittanceTimely Employer Remittance (0 reported on Line 4a)

Browse all 78,373 plans & Schedule C vendors · Methodology · Meru AI